Dabrafenib plus trametinib in unselected advanced BRAF V600-mut melanoma: a non-interventional, multicenter, prospective trial.
Richtig E, Nguyen VA, Koelblinger P, Wolf I, Kehrer H, Saxinger W, Ressler JM, Weinlich G, Meyersburg D, Hafner C, Jecel-Grill E, Kofler J, Lange-Asschenfeldt B, Weihsengruber F, Rappersberger K, Svastics N, Gasser K, Seeber A, Kratochvill F, Nagler S, Mraz B, Hoeller C.
Richtig E, et al. Among authors: mraz b.
Melanoma Res. 2024 Apr 1;34(2):142-151. doi: 10.1097/CMR.0000000000000948. Epub 2023 Dec 13.
Melanoma Res. 2024.
PMID: 38092013
Free PMC article.